Search filters

List of works by Alan Kennedy

A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells.

scientific article published on 18 August 2014

Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations

scientific article

Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function

scientific article published on 01 October 2019

Hematopoietic stem cell transplantation for CTLA4 deficiency

article

Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis

scientific article published on 15 July 2019

Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts.

scientific article published in December 2006

Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.

scientific article published on 3 February 2017

Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.

scientific article published in May 2015

Production and Concentration of Lentivirus for Transduction of Primary Human T Cells.

scientific article published in January 2016

Publisher Correction: Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis

scientific article published on 02 October 2019

Regulation of CTLA-4 recycling by LRBA and Rab11

scientific article published on 06 June 2021

Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells

scientific article published on September 16, 2011

Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells

scientific article

Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway.

scientific article published in September 2014